Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Current Problems in Cancer|August 23, 2020
Metastasectomy and BRAF mutation; an analysis of survival outcome in metastatic colorectal cancerThiru Prasanna, Rachel Wong, Timothy Price, et al.
Asia-Pacific Journal of Clinical Oncology|October 19, 2016
Prognostic significance of KIT exon 11 deletion mutation in intermediate-risk gastrointestinal stromal tumorRichard Quek, Mohamad Farid, Yada Kanjanapan, et al.
Clinical Colorectal Cancer|March 13, 2016
Impact of Primary Tumor Site on Bevacizumab Efficacy in Metastatic Colorectal CancerHui-Li Wong, Belinda Lee, Kathryn Field, et al.
Journal for Immunotherapy of Cancer|September 17, 2021
Simple and effective bacterial-based intratumoral cancer immunotherapyChristina S E Carroll, Erin R Andrew, Laeeq Malik, et al.
Cellular & Molecular Immunology|May 10, 2023
CTLA4 protects against maladaptive cytotoxicity during the differentiation of effector and follicular CD4<sup>+</sup> T cellsYuwei Hao, Bahar Miraghazadeh, Rochna Chand, et al.
European Journal of Cancer (Oxford, England : 1990)|October 23, 2018
Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infectionMartin Tio, Rajat Rai, Ogochukwu M Ezeoke, et al.
Cancers|March 25, 2022
Selective Targeting of Protein Kinase C (PKC)-θ Nuclear Translocation Reduces Mesenchymal Gene Signatures and Reinvigorates Dysfunctional CD8<sup>+</sup> T Cells in Immunotherapy-Resistant and Metastatic CancersJenny Dunn, Robert D McCuaig, Abel H Y Tan, et al.
Molecular Cancer Therapeutics|June 11, 2025
Depleting the action of EZH2 through PI3K-mTOR inhibition to overcome metastasis and immunotherapy resistance in triple-negative breast cancerMichelle Melino, Wen Juan Tu, Helle Bielefeldt-Ohmann, et al.
International Journal of Cancer|September 28, 2020
Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studiesJeanne Tie, Joshua D Cohen, Serigne N Lo, et al.
Nature Medicine|March 7, 2025
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trialJeanne Tie, Yuxuan Wang, Serigne N Lo, et al.
Pageof 11